A randomised comparison of ten versus three fractions of radiotherapy for palliation in patients unsuitable for radical radiotherapy or chemotherapy
| ISRCTN | ISRCTN56736625 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN56736625 |
| Protocol serial number | BA09 |
| Sponsor | Medical Research Council (MRC) (UK) |
| Funder | Medical Research Council (UK) |
- Submission date
- 28/02/2001
- Registration date
- 28/02/2001
- Last edited
- 11/09/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Barbara Uscinska
Scientific
Scientific
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | To compare the efficacy and side effects of two palliative radiotherapy schedules in patients with bladder cancer considered unsuitable for radical radiotherapy or chemotherapy. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Cancer |
| Intervention | Two palliative radiotherapy schedules in patients with bladder cancer considered unsuitable for radical radiotherapy or chemotherapy |
| Intervention type | Other |
| Primary outcome measure(s) |
Change in bladder and bowel symptoms at three months, quality of life, response, survival. |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/11/1997 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 500 |
| Key inclusion criteria | Life expectancy of at least three months, no planned administration of cytotoxic chemotherapy |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/11/1992 |
| Date of final enrolment | 01/11/1997 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results: | 01/05/2000 | Yes | No |
